# FDA Inspection 1203599 - Cooperman Barnabas Medical Center Inc - April 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/add98de2-9106-41e5-96fb-aee3743c176a
Source feed: FDA_Inspections

> FDA Inspection 1203599 for Cooperman Barnabas Medical Center Inc on April 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203599
- Company Name: Cooperman Barnabas Medical Center Inc
- Inspection Date: 2023-04-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1271693 - 2025-06-02](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/96f77e7a-5fe2-4654-a7f3-18149647f2fb)
- [FDA Inspection 1271693 - 2025-06-02](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/d2b967c3-f019-4ab6-8c5c-4ec94dc8e06b)
- [FDA Inspection 1102095 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/10cf26a0-c348-4ac7-9ec3-b73cf55c6eda)
- [FDA Inspection 903748 - 2014-11-07](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/32384c8f-f86a-47c9-b9be-d4cc2a3bf677)
- [FDA Inspection 829353 - 2013-04-29](https://www.keypedia.com/records/fda_inspections/cooperman-barnabas-medical-center-inc/abb068d9-bea2-4c9d-ae62-7ad1173a2f4b)

Company: https://www.keypedia.com/companies/cooperman-barnabas-medical-center-inc/ef493ab0-370a-4332-9280-ea8fe212cefa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d